Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly buys drug patch for $35m

Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical
Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical.

The drug contains a hormone that stimulates new bone growth. It is designed to be administered with a special device that creates tiny pores in the skin just prior to applying the patch.

Under the terms of the deal, should the patch gain approval, TransPharma will be eligible for milestone payments.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics